Literature DB >> 976626

Experimental colitis.

B MacPherson, C J Pfeiffer.   

Abstract

Ulcerative colitis and Crohn's disease are complex, problematic diseases of unknown etiology in man, and appropriate experimental models would be useful in elucidating their pathogenesis and treatment. Although there have been numerous attempts to produce inflammatory ulcerative colonic disease in laboratory animals resembling those human disease forms, none has been entirely successful. Investigators have conducted experiments involving almost every etiological factor suggested for initiation of these diseases. The methods reviewed in this paper include production of experimental colitis by vascular impairment, and immunological methods such as bacterial infection, allergic reactions, direct and indirect hypersensitivity reactions, as well as autoimmune mechanisms. The results of carrageenan-induced colitis, irradiation, dietary, and drug-induced techniques are also discussed and the frequency and nature of spontaneous colonic lesions in animals is summarized.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976626     DOI: 10.1159/000197966

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  16 in total

1.  Familial cutaneous photosensitivity and colitis with lethal outcome.

Authors:  P Labrune; P Huguet; D Alagille; M Odievre
Journal:  J Med Genet       Date:  1991-02       Impact factor: 6.318

Review 2.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

3.  Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation.

Authors:  W E Roediger; S Nance
Journal:  Br J Exp Pathol       Date:  1986-12

4.  Studies of the degraded carrageenan-induced colitis of rabbits. I. Changes in the epithelial glycoprotein O-acylated sialic acids associated with ulceration.

Authors:  A A Al-Suhail; P E Reid; C F Culling; W L Dunn; M G Clay
Journal:  Histochem J       Date:  1984-05

5.  Colonic inflammation in the rabbit induced by phorbol-12-myristate-13-acetate.

Authors:  D J Fretland; D L Widomski; S Levin; T S Gaginella
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

6.  Role of reactive oxygen metabolites in experimental colitis.

Authors:  A Keshavarzian; G Morgan; S Sedghi; J H Gordon; M Doria
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

7.  Dinitrochlorobenzene-induced colitis in the guinea-pig: studies of colonic lamina propria lymphocytes.

Authors:  M E Glick; Z M Falchuk
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

8.  Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis.

Authors:  A Keshavarzian; J Haydek; R Zabihi; M Doria; M D'Astice; J R Sorenson
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

9.  Cellular pathology of experimental colitis induced by trinitrobenzenesulphonic acid (TNBS): protective effects of recombinant human interleukin-11.

Authors:  C J Pfeiffer; S Sato; B S Qiu; J C Keith; S Evangelista
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 4.473

Review 10.  Role of eicosanoids in human and experimental colitis.

Authors:  R Schumert; J Towner; R D Zipser
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.